Displaying items by tag: department of medicine
C. Barrett Bowling, M.D., has received the Merck/American Geriatrics Society 2013 New Investigator Award
Agarwal’s appointment follows the Feb. 8, 2013, selection of former Dean and Senior Vice President Ray L. Watts, M.D., as the seventh president of UAB.
This year’s contribution brings the BCRFA's cumulative total donations for research at UAB to nearly $4 million.
Awards were given in four key areas — clinical care, medical education, laboratory research and patient-oriented research projects.
- awards and honors
- school of medicine
- department of radiation oncology
- department of neurology
- department of genetics
- division of gastroenterology and hepatology
- division of endocrinology diabetes and metabolism
- department of pharmacology and toxicology
- department of emergency medicine
- department of medicine
- division of infectious diseases
- division of general internal medicine
- center for exercise medicine
The latest edition of Best Doctors in America ® recognizes 325 UAB physicians — voted by their peers as the best.
- awards and honors
- school of medicine
- uab medicine
- division of cardiovascular disease
- division of gastroenterology and hepatology
- division of endocrinology diabetes and metabolism
- department of dermatology
- department of anesthesiology and perioperative medicine
- division of pulmonary allergy and critical care medicine
- department of medicine
- division of gerontology geriatrics and palliative care
UAB investigators will examine new technology, including iPads, as better tools to explain research studies to potential participants.
Black men and women have twice the risk of fatal coronary heart disease as whites, but the disparity could be eliminated with better risk factor control.
Researchers at UAB have performed the first U.S. trial of a foam sealant injected into the lungs.
The program works to reduce avoidable hospitalizations among nursing facility residents.
A combination of cancer drugs showed promise in killing triple-negative breast cancer cells.
The annual community event will be held Oct. 8.
Discovery may broaden clinical applications for a class of drugs that show promise for the treatment of familial breast and ovarian cancer.
UAB research team finds protein TLR9 holds key to predicting survival and aggressiveness of triple negative breast cancer.
Because most years see low incidence rates of West Nile, vaccine research is challenging; UAB experts say reach for the DEET.
CT scans can help physicians predict which COPD patients are likely to take a turn for the worse, say UAB researchers.